Jan P van Meerbeeck
机构: Universiteit Antwerpen - Universitair Ziekenhuis Antwerpen- Universiteit Gent
每年引用次数
引用次数
引用: 41,022
H-指数: 91
I10-指数 : 297
出版物: 716
Malignant pleural and peritoneal mesothelioma: clinical update 2018
Paul Van Schil , Jan Van Meerbeeck
Translational lung cancer research 7 ( 5) 505 -506
2018
Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (NSCLC) with METex14 skipping.
Xiuning Le , Enriqueta Felip , Remi Veillon , Hiroshi Sakai
Journal of Clinical Oncology 38 9556 -9556
4
2020
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Kim De Ruyck , Kristiaan Nackaerts , Laurence Beels , Joke Werbrouck
Pharmacogenomics 11 ( 8) 1053 -1063
36
2010
P1.03-078 Size Matters...but Don't Underestimate the Power of Morphology: Topic: Staging
Annemie Snoeckx , Damien Desbuquoit , Maarten Spinhoven , Annelies Janssens
Journal of Thoracic Oncology 12 ( 1)
2017
P1.04-028 Collection of ICHOM-Defined Patient-Reported Outcome Measures (PROMs) during Routine Lung Cancer Treatment: A Pilot Study: Topic: Pulmonology
Jan Van Meerbeeck , Lesley De Backer , Annelies Janssens , Birgitta Hiddinga
Journal of Thoracic Oncology 12 ( 1)
1
2017
OA02.07 Characterization of the Tumor Microenvironment and Investigation of Immune Checkpoint Expression in Malignant Pleural Mesothelioma
Elly Marcq , Vasiliki Siozopoulou , Jorrit De Waele , Jonas Van Audenaerde
Journal of Thoracic Oncology 12 ( 1) S249 -S250
2017
OA22.05 Breath Analysis by Gas Chromatography-Mass Spectrometry Can Be Used to Screen for Pleural Mesothelioma
Kevin Lamote , Lore Vandermeersch , Herman Van Langenhove , Joris Van Cleemput
Journal of Thoracic Oncology 12 ( 1) S331
2017
SC06.04 Immunotherapy of Malignant Pleural Mesothelioma and Thymic Malignancies: The End of the Beginning?
Jan Van Meerbeeck
Journal of Thoracic Oncology 12 ( 1) S92 -S94
2017
P2.06-027 Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Metastatic Pleural Mesothelioma: Topic: Mesothelioma and SCLC
Raffit Hassan , Ross Jennens , Jan Van Meerbeeck , John Nemunaitis
Journal of Thoracic Oncology 12 ( 1)
1
2017
Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
Kim De Ruyck , Marcin Szaumkessel , Isabelle De Rudder , Annelore Dehoorne
Mutation Research-genetic Toxicology and Environmental Mutagenesis 631 ( 2) 101 -110
186
2007
Surgery or radiotherapy for early-stage lung cancer—a potential comparison bias
Paul E Van Schil , Jan Van Meerbeeck
Lancet Oncology 14 ( 10)
9
2013
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects
Giuseppe Bronte , Christian Rolfo , Elisa Giovannetti , Giuseppe Cicero
Critical Reviews in Oncology Hematology 89 ( 2) 300 -313
49
2014
P3-079: Prospective evaluation of first-line tyrosine kinase inhibition with erlotinib in patients with advanced non-small cell lung cancer (NSCLC) harbouring a mutant EGFR gene (FIELT study)
Jacques L. De Gréve , Jan Van Meerbeeck , Johan Vansteenkiste , Denis Schallier
Journal of Thoracic Oncology 2 ( 8)
1
2007
B3-06: Interim safety results from TRUST, a global open-label study of erlotinib in patients with advanced non-small-cell lung cancer (NSCLC)
Andrea Ardizzoni , Evangelia Razis , Mikhail Lichinitser , Ugur Yilmaz
Journal of Thoracic Oncology 2 ( 8) S342 -342
3
2007
C5-03: Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)
Ulrich Gatzemeier , Paul Taylor , Joachim von Pawel , Bruno Castagneto
Journal of Thoracic Oncology 2 ( 8) S372 -S373
8
2007
PD1-2-5: Mediastinal Lymph Node Staging in lung cancer by integrated FDG-PET/CT based SUV value calculation. A prospective series
Kurt G. Tournoy , Sofie Maddens , Robert Gosselin , Mieke Kelles
Journal of Thoracic Oncology 2 ( 8) S418 -S419
2007
Coping strategy influences quality of life in patients with advanced lung cancer
Annelies Janssens , Sofie Derijcke , Danny Galdermans , Veerle Surmont
European Respiratory Journal 54
2019
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience
Lawek Berzenji , Dario Michaux , Suresh Krishan Yogeswaran , Annemie Van Breussegem
European Respiratory Journal
2020
The smellprint of mesothelioma cells: intrinsic biomarkers for diagnosis and subtyping
Eline Janssens , Elly Marcq , Lore Vandermeersch , Christophe Walgraeve
European Respiratory Journal
2020
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients
Eline Janssens , Kevin Lamote , Jan Van Meerbeeck , Lisa Brusselmans
European Respiratory Journal 52
3
2018